These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 3552774

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Insulin/C-peptide response to intravenous glucagon. A dose-response study in normal and non-insulin-dependent diabetic subjects.
    Snorgaard O, Hasselstrøm K, Lumholtz IB, Thorsteinsson B, Siersbaek-Nielsen K.
    Acta Endocrinol (Copenh); 1988 Jan; 117(1):109-15. PubMed ID: 3289292
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Correlations between fasting plasma C-peptide, glucagon-stimulated plasma C-peptide, and urinary C-peptide in insulin-treated diabetics.
    Gjessing HJ, Matzen LE, Frøland A, Faber OK.
    Diabetes Care; 1987 Jan; 10(4):487-90. PubMed ID: 3304899
    [Abstract] [Full Text] [Related]

  • 29. The C-peptide response to glucagon injections in IDDM and NIDDM patients.
    Poulsen S, Billesbølle P, Kølendorf K, Thorsteinsson B.
    Horm Metab Res; 1985 Jan; 17(1):39-40. PubMed ID: 3967844
    [No Abstract] [Full Text] [Related]

  • 30. Clinical significance of urinary C-peptide excretion in children with insulin-dependent diabetes mellitus.
    Huttunen NP, Knip M, Käär ML, Puukka R, Akerblom HK.
    Acta Paediatr Scand; 1989 Mar; 78(2):271-7. PubMed ID: 2648764
    [Abstract] [Full Text] [Related]

  • 31. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.
    Faber OK, Binder C.
    Diabetes; 1977 Jul; 26(7):605-10. PubMed ID: 326604
    [Abstract] [Full Text] [Related]

  • 32. Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon.
    Hendriksen C, Faber OK, Drejer J, Binder C.
    Diabetologia; 1977 Dec; 13(6):615-9. PubMed ID: 338408
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Plasma C-peptide assay and the clinical significance].
    Kaku K, Nagasaka Y, Kaneko T.
    Nihon Rinsho; 1990 Feb; 48 Suppl():48-50. PubMed ID: 2192142
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Metabolic control and B cell function in patients with insulin-dependent diabetes mellitus secondary to chronic pancreatitis.
    Larsen S, Hilsted J, Tronier B, Worning H.
    Metabolism; 1987 Oct; 36(10):964-7. PubMed ID: 3309547
    [Abstract] [Full Text] [Related]

  • 39. Urinary C-peptide: a useful tool for evaluating the endogenous insulin reserve in cohort and longitudinal studies of diabetes in childhood.
    de Beaufort CE, den Boer NC, Bruining GJ, Eilers GA, van Strik R, Weterings T.
    Ann Clin Biochem; 1988 Sep; 25 ( Pt 5)():552-9. PubMed ID: 3069047
    [Abstract] [Full Text] [Related]

  • 40. Reevaluation of urine C-peptide as measure of insulin secretion.
    Tillil H, Shapiro ET, Given BD, Rue P, Rubenstein AH, Galloway JA, Polonsky KS.
    Diabetes; 1988 Sep; 37(9):1195-201. PubMed ID: 3044885
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.